EUVIMEDEUVIMED entdecken
Open Access

SARS ‐ CoV ‐2 IgG antibodies in COVID ‐19 convalescent plasma and conventional plasma units

Andrew Sulaiman, Isabella Sengsouk, Jodie L White, Christi Marshall, Reinaldo E Fernandez, Andrew D Redd, Yolanda Eby, Arturo Casadevall, David Sullivan iD, Kelly Gebo, Shmuel Shoham, Oliver Laeyendecker und 4 weitere

Transfusion · 2025

DOI: 10.1111/trf.18139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Andrew Sulaiman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral, Antibodies, Neutralizing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Association for the Advancement of Blood and Biotherapies guidelines recommend the use of high‐titer COVID‐19 convalescent plasma (CCP) for patients with SARS‐CoV‐2 at high risk of disease progression, including those who are immunocompromised. We hypothesized that conventional plasma units have comparable neutralizing antibody levels to CCP. Study Design and Methods Conventional plasma and CCP units were obtained from blood suppliers. Quantitatively measured antibodies to SARS‐CoV‐2 were assessed using the MesoScale Discovery multiplex electrochemiluminescence immunoassay. Binding antibody distributions were compared with Wilcoxon rank‐sum tests. SARS‐CoV‐2 neutralizing antibodies were analyzed using the GeneScript ELISA‐based neutralization assay. The proportion of conventional and CCP units with a percent signal inhibition of ≥80% (as defined by the United States Food and Drug Administration for CCP in 2021) and exact binomial confidence intervals (CIs) were calculated.

Results

Among 218 conventional plasma units and 74 CCP units collected between September 2023 and July 2024, the distribution of total antibody binding levels largely overlapped between conventional plasma and CCP, though statistically significant differences in median nucleocapsid and spike Omicron variant concentrations were observed. Median percent signal neutralization was 97.5% (range 3.4%–98.6%) among conventional plasma units and 97.7% (range 95.4%–98.6%) among CCP units. For conventional plasma, 95.0% (95% CI = 91.2%–97.5%) met the neutralization antibody threshold for high‐titer CCP. For CCP, 100% (95% CI = 95.1%–100.0%) met the neutralization threshold for high‐titer CCP.

Conclusion

Conventional plasma units demonstrate similar median antibody concentration to CCP units. In countries or regions where licensed CCP is unavailable and titers are unknown, transfusion of multiple conventional plasma units may be of clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antibodies, ViralAntibodies, NeutralizingImmunoglobulin GPlasmaHumansCOVID-19 SerotherapyImmunization, PassiveMale

Substanzen

Antibodies, ViralAntibodies, NeutralizingImmunoglobulin G

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: David Sullivan, Herleen Rai, Evan M Bloch, Elizabeth P Crowe, Aaron A R Tobian

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Sulaiman, A., Sengsouk, I., White, J. L., Marshall, C., Fernandez, R. E., Redd, A. D., Eby, Y., Casadevall, A., Sullivan, D., Gebo, K., Shoham, S., Laeyendecker, O., Rai, H., Bloch, E. M., Crowe, E. P., & Tobian, A. A. R. (2025). SARS ‐ CoV ‐2 IgG antibodies in COVID ‐19 convalescent plasma and conventional plasma units. Transfusion. https://doi.org/10.1111/trf.18139

Vancouver

Sulaiman A, Sengsouk I, White JL, Marshall C, Fernandez RE, Redd AD, et al. SARS ‐ CoV ‐2 IgG antibodies in COVID ‐19 convalescent plasma and conventional plasma units. Transfusion. 2025. doi:10.1111/trf.18139

BibTeX
@article{Sulaiman2025,
  author = {Sulaiman, Andrew and Sengsouk, Isabella and White, Jodie L and Marshall, Christi and Fernandez, Reinaldo E and Redd, Andrew D and Eby, Yolanda and Casadevall, Arturo and Sullivan, David and Gebo, Kelly and Shoham, Shmuel and Laeyendecker, Oliver and Rai, Herleen and Bloch, Evan M and Crowe, Elizabeth P and Tobian, Aaron A R},
  title = {SARS ‐ CoV ‐2 IgG antibodies in COVID ‐19 convalescent plasma and conventional plasma units},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18139}
}
Kostenlos starten →